Balance Sheet - Legend Biotech Corp (LEGN)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 948.60 | 1,122.68 | 1,308.72 | 1,025.65 | 882.40 | 506.07 | 158.92 | 216.18 | 2.12 |
| Accounts receivable, net | 250.30 | 124.89 | 157.06 | 44.52 | 58.55 | 82.62 | 35.76 | 108.57 | 228.74 |
| Inventories | 32.00 | 23.90 | 19.43 | 10.35 | 1.75 | 1.80 | 1.16 | 1.14 | 0.01 |
| Other current assets | 16.20 | 12.44 | 12.59 | 18.60 | 7.16 | 3.46 | 11.27 | 1.07 | 0.79 |
| Total current assets | 1,247.10 | 1,283.92 | 1,497.80 | 1,099.12 | 949.85 | 593.94 | 207.10 | 326.96 | 230.90 |
| Total non-current assets | 486.60 | 386.24 | 350.81 | 231.84 | 169.62 | 128.15 | 80.61 | 102.09 | 7.79 |
| Total assets | 1,733.70 | 1,670.15 | 1,848.61 | 1,330.96 | 1,119.47 | 722.09 | 287.72 | 429.05 | 238.69 |
| Total current liabilities | 636.40 | 277.65 | 216.42 | 297.79 | 229.20 | 115.57 | 127.76 | 159.19 | 52.12 |
| Total non-current liabilities | 95.20 | 351.96 | 380.82 | 288.86 | 124.32 | 6.70 | 282.82 | 261.21 | 174.40 |
| Total liabilities | 731.60 | 629.61 | 597.24 | 586.65 | 353.52 | 122.27 | 410.58 | 420.40 | 226.53 |
| Total stockholders' equity | 1,002.10 | 1,040.55 | 1,251.37 | 744.31 | 765.94 | 597.77 | -122.87 | 8.65 | 12.17 |
| Common shares outstanding | 184 | 183 | 176 | 159 | 141 | 118 | 132 | 100 | 132 |
Show Quarterly Balance Sheet
Balance Sheet - Legend Biotech Corp (LEGN)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 834.63 | 948.60 | 992.59 | 967.56 | 1,005.38 | 1,122.68 | 1,212.40 | 1,291.84 | 1,302.38 | 1,308.72 | 1,423.84 | 1,514.78 | 850.12 | 1,025.65 | 840.05 | 783.11 | 791.26 | 882.40 | 635.93 | 692.71 | 462.30 | 506.07 | 576.12 | 637.95 | 246.48 | 158.92 | 0.00 | 0.00 | 216.18 |
| Accounts receivable, net | 186.61 | 250.30 | 202.57 | 228.99 | 166.85 | 124.89 | 103.98 | 101.38 | 77.96 | 157.06 | 49.69 | 62.90 | 51.82 | 44.52 | 0.28 | 0.46 | 67.10 | 58.55 | 15.34 | 26.17 | 10.43 | 82.62 | 24.66 | 33.52 | 23.16 | 29.99 | |||
| Inventories | 37.10 | 32.00 | 29.18 | 35.59 | 30.93 | 23.90 | 23.55 | 18.87 | 22.15 | 19.43 | 18.01 | 15.20 | 12.18 | 10.35 | 10.35 | 8.16 | 2.90 | 1.75 | 1.63 | 1.70 | 2.10 | 1.80 | 1.51 | 1.67 | 1.33 | 1.16 | |||
| Other current assets | 24.40 | 16.20 | 17.66 | 17.74 | 15.63 | 12.44 | 10.11 | 12.75 | 11.31 | 12.59 | 17.26 | 19.99 | 1.28 | 18.60 | 62.84 | 44.22 | 1.45 | 7.16 | 0.46 | 0.26 | 0.26 | 3.46 | 0.43 | 0.26 | 23.41 | 17.03 | |||
| Total current assets | 1,082.73 | 1,247.10 | 1,242.00 | 1,249.87 | 1,218.79 | 1,283.92 | 1,350.04 | 1,424.83 | 1,413.79 | 1,497.80 | 1,508.80 | 1,612.86 | 915.40 | 1,099.12 | 1,099.12 | 835.95 | 862.71 | 949.85 | 653.36 | 720.83 | 475.07 | 593.94 | 602.72 | 673.39 | 271.22 | 207.10 | 216.18 | ||
| Total non-current assets | 514.02 | 486.60 | 470.94 | 440.04 | 396.86 | 386.24 | 385.79 | 373.35 | 361.32 | 350.81 | 330.54 | 317.80 | 293.96 | 231.84 | 164.17 | 186.80 | 177.81 | 169.62 | 160.40 | 154.29 | 140.18 | 128.15 | 105.92 | 99.47 | 93.71 | 80.61 | -216.18 | ||
| Total assets | 1,596.75 | 1,733.70 | 1,712.95 | 1,689.91 | 1,615.65 | 1,670.15 | 1,735.83 | 1,798.18 | 1,775.11 | 1,848.61 | 1,839.33 | 1,930.66 | 1,209.36 | 1,330.96 | 1,330.96 | 1,022.75 | 1,040.52 | 1,119.47 | 813.77 | 875.13 | 615.25 | 722.09 | 708.64 | 772.87 | 364.94 | 287.72 | 287.72 | 287.72 | 287.72 |
| Total current liabilities | 509.12 | 636.40 | 433.57 | 265.48 | 234.37 | 277.65 | 270.89 | 294.30 | 249.68 | 216.42 | 175.22 | 201.38 | 238.18 | 297.79 | 297.79 | 259.76 | 225.53 | 229.20 | 275.37 | 261.10 | 145.94 | 115.57 | 123.52 | 115.03 | 112.43 | 127.76 | |||
| Total non-current liabilities | 119.90 | 95.20 | 268.12 | 388.89 | 363.53 | 351.96 | 348.82 | 344.88 | 361.37 | 380.82 | 324.48 | 322.25 | 318.02 | 288.86 | 260.93 | 200.36 | 376.42 | 124.32 | 312.53 | 274.11 | 262.86 | 6.70 | 250.22 | 256.83 | 268.39 | 282.82 | |||
| Total liabilities | 629.02 | 731.60 | 701.69 | 654.38 | 597.90 | 629.61 | 619.72 | 639.18 | 611.05 | 597.24 | 499.70 | 523.63 | 556.20 | 586.65 | 586.65 | 460.11 | 601.95 | 353.52 | 587.90 | 535.21 | 408.80 | 122.27 | 373.74 | 371.86 | 380.82 | 410.58 | |||
| Total stockholders' equity | 967.73 | 1,002.10 | 1,011.26 | 1,035.54 | 1,017.75 | 1,040.55 | 1,116.11 | 1,159.00 | 1,164.06 | 1,251.37 | 1,339.64 | 1,407.03 | 653.16 | 744.31 | 744.31 | 562.63 | 438.56 | 765.94 | 225.87 | 339.92 | 206.45 | 597.77 | 334.90 | 401.00 | -15.88 | -122.87 | 8.65 | ||
| Common shares outstanding | 185 | 185 | 185 | 184 | 184 | 183 | 183 | 183 | 182 | 182 | 182 | 175 | 165 | 159 | 157 | 155 | 154 | 147 | 145 | 139 | 133 | 132 | 132 | 108 | 129 | 100 | 100 | 100 | 100 |